Gene · 1638
Papers2,693
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,693
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anti-melanogenic effect of exosomes derived from human dermal fibroblasts (BJ-5ta-Ex) in C57BL/6 mice and B16F10 melanoma cells. | Pigment Cell Melanoma Res | 2024 | 37758515 | PubTator, text mining | PubMed |
Potential role of the cell-penetrating peptide-conjugated soluble N-ethylmaleimide-sensitive factor attachment protein receptor motif of vesicle-associated membrane protein 2-patterned peptide in novel cosmeceutical skin product development. | J Cosmet Dermatol | 2024 | 37698157 | PubTator, text mining | PubMed |
| Gynostemma pentaphyllum Makino extract induces hair growth and exhibits an anti-graying effect via multiple mechanisms. | J Cosmet Dermatol | 2024 | 37649302 | PubTator, text mining | PubMed |
| Combination of a MIP3α-antigen fusion therapeutic DNA vaccine with treatments of IFNα and 5-Aza-2'Deoxycytidine enhances activated effector CD8+ T cells expressing CD11c in the B16F10 melanoma model. | Res Sq | 2024 | 37645859 | PubTator, text mining | PubMed |
| Hemolytic disease of the fetus and newborn due to minor blood group alloimmunization in a mother of sickle cell disease with multiple alloantibodies. | Asian J Transfus Sci | 2023 | 38274971 | PubTator, text mining | PubMed |
| Comparative Studies on the Photoreactivity, Efficacy, and Safety of Depigmenting Agents. | Pharmaceuticals (Basel) | 2023 | 38256889 | PubTator, text mining | PubMed |
| Promising and Minimally Invasive Biomarkers: Targeting Melanoma. | Cells | 2023 | 38201222 | PubTator, text mining | PubMed |
| Efficacy and safety of metformin for melasma treatment: a systematic review and meta-analysis. | Front Pharmacol | 2023 | 38192412 | PubTator, text mining | PubMed |
| Antioxidant mechanisms of mesenchymal stem cells and their therapeutic potential in vitiligo. | Front Cell Dev Biol | 2023 | 38178870 | PubTator, text mining | PubMed |
| Biological Activity of Fermented Plant Extracts for Potential Dermal Applications. | Pharmaceutics | 2023 | 38140115 | PubTator, text mining | PubMed |
| Advocacy of Precision Allergy Molecular Diagnosis in Decision Making for the Eligibility of Customized Allergen Immunotherapy. | Curr Issues Mol Biol | 2023 | 38132469 | PubTator, text mining | PubMed |
| Regulatory and Interacting Partners of PDLIM7 in Thyroid Cancer. | Curr Oncol | 2023 | 38132395 | PubTator, text mining | PubMed |
| Gauging Quince Phytonutrients and Its 4% Emulgel Effect on Amplifying Facial Skin Moisturizing Potential. | Gels | 2023 | 38131920 | PubTator, text mining | PubMed |
| Exosomal miRNAs in autoimmune skin diseases. | Front Immunol | 2023 | 38106405 | PubTator, text mining | PubMed |
| Predictive modelling framework on the basis of artificial neural network: A case of nano-powder mixed electric discharge machining. | Heliyon | 2023 | 38094058 | PubTator, text mining | PubMed |
| Identification of Dopachrome Tautomerase (DCT) and Kinesin Family Member 1A (KIF1A) as Related Biomarkers and Immune Infiltration Characteristics of Vitiligo Based on Lasso-SVM Algorithms. | Clin Cosmet Investig Dermatol | 2023 | 38084289 | PubTator, text mining | PubMed |
| Biology of melanocytes in mammals. | Front Cell Dev Biol | 2023 | 38078014 | PubTator, text mining | PubMed |
| Alteration in Melanin Content in Retinal Pigment Epithelial Cells upon Hydroquinone Exposure. | Int J Mol Sci | 2023 | 38069124 | PubTator, text mining | PubMed |
| Chemical Composition and Skin-Whitening Activities of Siegesbeckia glabrescens Makino Flower Absolute in Melanocytes. | Plants (Basel) | 2023 | 38068567 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis of corneal organoids during development. | Stem Cell Reports | 2023 | 38039970 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1638/papers?page=8